Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Nov
3
2017
Impact of Cyberattack on Merck was $135 million K&L Gates
Jul
14
2021
Sizing up The Scale of Mena's Potential Role in The Hydrogen Economy Share via Linked In [PODCAST] K&L Gates
Jun
21
2022
EPA Proposes New Rules Governing Section 401 Water Quality Certification K&L Gates
Sep
29
2022
QR Code and Text Messaging Alone Are Insufficient to Disclose Bioengineered Food Ingredients K&L Gates
Dec
8
2022
FDA Releases Traceability Final Rule K&L Gates
Jan
6
2023
Perrigo Co. v. Abbvie Inc. - Third Circuit Holds Mutual Release Bars Generic Drug Company’s Antitrust Claim Alleging That “Sham” Patent Infringement Litigation Delayed Generic Drug Launch K&L Gates
Jul
27
2020
President Trump Signs Drug Pricing Executive Orders Reinforcing the Administration's Priorities K&L Gates
Sep
26
2020
340B UPDATE: Congress and the Administration Respond to Drug Manufacturers' 340B Contract Pharmacy Actions K&L Gates
Apr
19
2017
Abbott Labs Makes Costly Mistake as FDA Targets Cybersecurity Deficiencies K&L Gates
Apr
2
2021
Cannabis Banking; The SAFE Banking Act 2.0's Status, Key Modifications, and Prospects K&L Gates
May
14
2021
Introduction of a Patent Box K&L Gates
Oct
20
2021
US Regulatory Considerations Applicable to Digital Health Providers and Suppliers - Part III: FDCA K&L Gates
Oct
28
2021
What Health Care Providers Should Expect in an FDA Inspection [PODCAST] K&L Gates
Jan
18
2022
COVID-19 Vaccination Sweepstakes: Best Practices for Employee Incentives K&L Gates
Jul
23
2019
Court Of Chancery Denies Application For Certification Of Interlocutory Appeal After Ruling That Judicial Dissolution Of The Limited Liability Company Is Warranted K&L Gates
Aug
22
2019
In A Reckless Re-Price, Results Are Not Realized K&L Gates
Jul
26
2017
Massachusetts’s Highest Court Rules that Employee Fired for Medical Marijuana Use Can Hold Employer Liable for Discrimination K&L Gates
Jul
7
2021
340B Update: Delaware Court Denies 340B Program Statute Requiring Contract Pharmacy Arrangements K&L Gates
Jul
13
2018
Australian Liquor Company may not get Off Scot(ch) Free K&L Gates
May
2
2022
Litigation Minute: Defending Consumer Class Action Claims Involving PFAS K&L Gates
Jul
15
2022
New FDA Draft Guidance Aiming to Prevent Drug Shortages Will Affect Pharmaceutical Manufacturers K&L Gates
Jul
18
2019
Producers of Generic Medicines and Biosimilars even More Supported by EU K&L Gates
Jun
4
2023
Highlights for Research Institutions and Sponsors in FDA's Recent Draft Guidance on Decentralized Clinical Trials K&L Gates
Aug
15
2023
Tea Parties Certified For Class Action K&L Gates
Jun
8
2020
COVID-19: 340B Update: HRSA Updates Guidance Granting New HOPD Flexibility K&L Gates
Jul
6
2017
Sandoz v. Amgen – Biosimilars at the U.S. Supreme Court K&L Gates
Aug
28
2017
How Distinctive Can a Chocolate Bar be? After Kit Kat, Now It’s Toblerone’s Turn K&L Gates
Apr
20
2021
Cannabis Banking: The Safe Banking Act 2.0 Passes the House of Representatives K&L Gates
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins